title: Commentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease".
authors: Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. esiemers@lilly.com
authors: Eric R
authors: ER
authors: Siemers